USPTO serial 79377906
NIPRO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 14, 2025
- Examiner
- MASON, JARED MICHAEL
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NIPRO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jerald E. Nagae, Reg. No. 29,418
Jerald E. Nagae, Reg. No. 29,418 Christensen O'Connor Johnson Kindness1201 Third Avenue, Suite 36002-4, Nakanoshima 3-chome,Seattle, WA 98101Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antipyretic analgesics; Hypnotic sedatives; Topical anesthetics; Pharmaceutical preparations for the treatment and prevention of Parkinson's disease; Ophthalmic preparations; Pharmaceutical preparations for otic and nasal spray use; Pharmaceutical preparations, namely, antiallergic agents; Pharmaceutical preparations, namely, antihypertensives; Antiarrhythmic agents; Diuretics; Respiratory stimulants; Antiemetics; Anti-tussive expectorants; Antacids; Hormones for medical purposes; Vitamin preparations; Anticoagulants; Blood substitute for human and veterinary use; Tumor suppressing agents; Antibiotic preparations; Antivirals; Antimicrobial preservatives for pharmaceuticals; Antidiabetic preparations; Prescription synthetic narcotics; pharmaceutical solutions used in dialysis; dried dialysate being pharmaceutical solutions used in dialysis; disinfectants for medical apparatus and instruments; stem cell preparations for the treatment of diseases and disorders; cell culture reagents for medical purposes; bacteriological culture mediums for medical purposes or veterinary purposes; cells for medical purposes; diagnostic reagents for medical purposes; medical diagnostic test strips for blood analysis; test strips for measuring blood glucose levels; empty capsules for pharmaceutical purposes; sticking plasters for medical use; medical and surgical dressings; antiseptic cotton; incontinence diapers; pharmaceutical preparations for dental purposes for the treatment of cavities; embedding material for dental purposes, namely, dental plasters; sealing agents for dental purposes; dental ceramics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 8, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 22, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 21, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 14, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 15, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 27, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 26, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 14, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 14, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 17, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 17, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 28, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 15, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 15, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 15, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 15, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 15, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 9, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 9, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 9, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 11, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 14, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 14, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 26, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 25, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 23, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 2, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 22, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 18, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 14, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 31, 2023 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |